Aggrastat

Aggrastat (Tirofiban Hydrochloride Monohydrate) is an intravenous medication used to prevent blood clots. It is commonly used during certain heart procedures to reduce the risk of clotting. This medication is manufactured by Advanz Pharma Limited.

Aggrastat is primarily used to prevent blood clots in patients undergoing certain heart procedures, such as angioplasty. It works by inhibiting platelet aggregation, which helps to keep blood flowing smoothly. This medication is often used in combination with other treatments to manage heart-related conditions.

Aggrastat may cause common side effects such as nausea, headache, and bleeding at the injection site. Some patients may also experience dizziness or low blood pressure. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

Aggrastat should be used with caution in patients with a history of bleeding disorders or recent surgery. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Always follow the prescribed dosage and administration instructions provided by your healthcare provider.

Aggrastat may interact with other medications that affect blood clotting, such as anticoagulants and antiplatelet drugs. It is also important to avoid alcohol while using this medication, as it can increase the risk of bleeding. Always consult your healthcare provider before starting or stopping any medication while using Aggrastat.